您的位置: 首页 > 农业专利 > 详情页

peptide; nucleic acid; binding portion; pharmaceutical composition; peptides and / or nucleic acids and / or binding moieties; peptides and / or nucleic acids and / or binding moieties for use; and nucleic acid for use
专利权人:
SCANCELL LIMITED
发明人:
LINDA GILLIAN DURRANT,RACHEL LOUISE METHERINGHAM,VICTORIA ANNE BRENTVILLE
申请号:
BR112017025036
公开号:
BR112017025036A2
申请日:
2016.07.19
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
The present invention relates to modified citrullinated enolase peptides which may be used as targets for cancer immunotherapy. These peptides may be used as vaccines or as targets for monoclonal antibody (mab) therapy. These vaccines or mabs can be used to treat cancer.a presente invenção refere-se a peptídeos de enolase citrulinados modificados que podem ser utilizados como alvos para imunoterapia para câncer. estes peptídeos podem ser utilizados como vacinas ou como alvos para terapia de anticorpo monoclonal (mab). essas vacinas ou mabs podem ser utilizados no tratamento de câncer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充